Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum [3]

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 7, 2007, Pages 2654-2655

  Pradines, Bruno ^a   Torrentino Madamet, Marylin ^a   Fontaine, Albin ^a   Henry, Maud ^a   Baret, Eric ^a   Mosnier, Joel ^a   Briolant, Sebastien ^a   Fusai, Thierry ^a   Rogier, Christophe ^a  

^a SERVICE DE SANTÉ DES ARMÉES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CHLOROQUINE; COMPACTIN; FLUINDOSTATIN; MEVINOLIN; PRAVASTATIN; SIMVASTATIN; STATINE DERIVATIVE;

CELL VIABILITY; IC 50; IN VITRO STUDY; LEISHMANIA; LETTER; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; STEADY STATE; TRYPANOSOMA CRUZI;

ANIMALS; ANTIMALARIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INHIBITORY CONCENTRATION 50; MALARIA, FALCIPARUM; MICROBIAL SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; PYRROLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34447263020     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01330-06     Document Type: Letter

References (13)

1. Borek-Dohalsky, V., J. Huclova, B. Barrett, B. Nemec, I. Ulc, and I. Jelinek. 2006. Validated HPLC-MS-MS method for simultaneous determination of atorvastatin and 2-hydroxyatorvastatin in human plasma-pharmacokinetic study. Anal. Bioanal. Chem. 386:275-285.
2. Catron, D. M., Y. Lange, J. Borenztajn, M. D. Sylvester, B. D. Jones, and K. Haldar. 2004. Salmonella enterica serovar Typhimurium requires nonsterol precursors of the cholesterol biosynthetic pathway for intracellular proliferation. Infect. Immun. 72:1036-1042.
3. Coppens, I., P. Bastin, T. Levade, and P. J. Courtoy. 1995. Activity, pharmacological inhibition and biological regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in Trypanosoma brucei. Mol. Biochem. Parasitol. 69:29-40.
4. Couto, A. S., E. A. Kimura, V. J. Peres, M. L. Uhrig, and A. M. Katzin. 1999. Active isoprenoid pathway in the intra-erythrocytic stages of Plasmodium falciparum: presence of dolichols of 11 and 12 isoprene units. Biochem. J. 341:629-637.
5. Grellier, P., A. Valentin, V. Millerioux, J. Schrevel, and D. Rigomier. 1994. 3-Hydroxy-methylglutaryl coenzyme A reductase inhibitors lovastatin and simvastatin inhibit in vitro development of Plasmodium falciparum and Babesia divergens in human erythrocytes. Antimicrob. Agents Chemother. 38:1144-1148.
6. Holtzman, C. W., B. S. Wiggings, and S. A. Spinier. 2006. Role of P-glycoprotein in statin drug interaction. Pharmacotherapy 26:1601-1607.
7. Kaufmann, P., M. Torok, A. Zahno, K. M. Walhauser, K. Brecht, and S. Krahenbuhl. 2006. Toxicity of statins on rat skeletal muscle mitochondria. Cell. Mol. Life Sci. 63:2415-2425.
8. Montalvetti, A., J. Pana-Diaz, R. Hurtado, L. M. Ruiz-Perez, and D. Gonza lez-Pacanowska. 2000. Characterization and regulation of Leishmania major 3-hydroxy-methyl-glutaryl-CoA reductase. Biochem. J. 349:27-34.
9. Naik, R. S., M. Venkatesan, and D. C. Gowda. 2001. Plasmodium falciparum: the lethal effects of tunicamycin and mevastatin on the parasite are not mediated by inhibition of N-linked oligosaccharide biosynthesis. Exp. Parasitol. 98:110-114.
10. Pradines, B., J. M. Rolain, F. Ramiandrasoa, T. Fusai, J. Mosnier, C. Rogier, W. Daries, E. Baret, G. Kunesch, J. Le Bras, and D. Parzy. 2002. Iron chelators as antimalarial agents: in vitro activity of dicatecholate against Plasmodium falciparum. J. Antimicrob. Chemother. 50:177-187.
11. Song, J. L., C. N. Lyons, S. Holleman, B. G. Oliver, and T. C. White. 2003. Antifungal activity of fluconazole in combination with lovastatin and their effects on gene expression in the ergosterol and prenylation pathways in Candida albicans. Med. Mycol. 41:417-425.
12. Urbina, J. A., K. Lazardi, E. Marchan, G. Visbal, T. Aguirre, M. M. Piras, R. Piras, R. A. Maldonado, G. Payares, and W. de Souza. 1993. Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Antimicrob. Agents Chemother. 37:580-591.
13. Yokoyama, K., P. Trobridge, F. S. Buckner, J. Scholten, K. D. Stuart, W. C. van Voorhis, and M. H. Gelb. 1998. The effects of protein farnesyltransferase inhibitors on trypanosomatids: inhibition of protein farnesylation and cell growth. Mol. Biochem. Parasitol. 94:87-97.